Abstract
Importance As with other traumatic events, pandemics such as coronavirus-19 (COVID- 19) may precipitate or exacerbate psychiatric symptoms such as anxiety and depression, while potentially interfering with health systems’ capacity to treat such symptoms.
Objective To quantify the impact of increasing COVID-19 infection on extent of psychiatric assessment across 5 Eastern Massachusetts hospitals.
Design In silico cohort using narrative clinical notes generated between 1/2/2020 and 3/25/2020.
Setting Emergency department and outpatient settings from 2 academic medical centers and 3 community hospitals.
Participants All individuals age 13 and older presenting to emergency department or outpatient clinics.
Main Outcome or Measure Documentation of psychiatric symptoms reflecting depression, anxiety, psychosis, or suicide, and documentation of violence, was drawn from previously-validated term lists.
Results A total of 2,483,159 outpatient and 205,957 emergency department visit notes were analyzed. Instances of notes referencing depression or anxiety decreased 75-81% in outpatient settings with onset of coronavirus in March 2019, and by 44-45% in emergency departments. In adjusted logistic regression, presence of individual psychiatric symptoms in outpatient notes was associated with significant decreases in likelihood of coronavirus testing (for depression, OR=0.636, 95% CI 0.606-0.667). Conversely, presence of violence in an emergency department note was associated with greater likelihood of testing (OR=1.487, 95% CI 1.249-1.761).
Conclusions and Relevance Documentation of psychiatric symptoms in both outpatient and emergency department settings diminished sharply in the context of increasing coronavirus infection in Massachusetts, suggesting that efforts to provide additional resources to manage psychiatric symptoms will be needed.
Funding none.
Question How did documentation of psychiatric symptoms in outpatient and emergency room settings change with onset of COVID-19 infection in Eastern Massachusetts?
Findings In this cohort study spanning 2 academic medical centers and 3 community hospitals, prevalence of narrative notes referencing depression or anxiety decreased 75-81% in outpatient settings following onset of coronavirus in March 2019, and by 44-45% in emergency departments.
Meaning The observation that documentation of psychiatric symptoms declined sharply with increasing coronavirus infection in Massachusetts, even as prevalence of such symptoms is anticipated to increase, suggests additional efforts may be required to address these symptoms in the context of COVID-19.
Competing Interest Statement
Dr. Perlis has received consulting fees from Burrage Capital, Genomind, RID Ventures, and Takeda. He holds equity in Outermost Therapeutics and Psy Therapeutics. Mr. Castro reports no conflict of interest.
Funding Statement
No external funding was received.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Participant-level data has not been approved for release by the IRB.